# Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

> **NCT02180412** · PHASE2 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 20 (actual)

## Conditions studied

- Acute Porphyrias

## Interventions

- **BIOLOGICAL:** Panhematin
- **OTHER:** Glucose

## Key facts

- **NCT ID:** NCT02180412
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-28
- **Primary completion:** 2022-02-03
- **Final completion:** 2022-02-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180412, "Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02180412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*